We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Minimally Invasive Cancer Diagnostic Device Eavesdrops On Cells’ Conversations

By LabMedica International staff writers
Posted on 26 Oct 2023

For a long time, scientists have understood that RNA (ribonucleic acid) serves as an internal messenger within cells, taking DNA's instructions to help the cells produce proteins. More...

However, a recent discovery shows that specific kinds of RNA, termed "extracellular RNA" or exRNA, actually leave the cell. These exRNAs are enclosed in tiny carrier structures and travel through bodily fluids, acting like tiny informational messages in bottles. These exRNAs are incredibly valuable as they could hold early indicators for diseases like cancer, heart disease, and HIV. Detecting diseases via exRNA could be quicker, more effective, and cheaper than current techniques. The challenge, however, has been separating and interpreting these exRNAs, as existing methods like advanced filters and centrifuges haven't been very successful.

A team of scientists at the University of Notre Dame (Notre Dame, IN, USA) has created a groundbreaking device that uses an ingenious approach to 'eavesdrop' on cells’ conversations. This palm-sized device combines existing technologies and employs a mix of pH levels and electrical charges to segregate the exRNA carriers. The unique feature here is that each type of carrier has its own "isoelectric point," a particular pH level at which it has no positive or negative charge. Within the device, there's a seemingly simple stream of water flowing. But this stream is special. On the left side, the water is highly acidic, similar to grapefruit juice. On the opposite end of the stream, the water is extremely basic, with a pH similar to a bottle of ammonia. What's particularly remarkable about the device is its ability to generate this pH gradient in the stream without adding any chemicals, making it cost-effective and eco-friendly.

This gradient is made possible by a two-sided membrane that's powered by a custom-designed chip. This membrane divides the water into two types of ions: acidic hydronium ions and basic hydroxide ions, adding a different kind of ion to each side of the stream. As these acidic and basic streams converge, they form a pH gradient, much like how hot and cold streams form hot and cold sides with a gradient of temperature through the middle of the stream. The researchers ran the two devices in parallel and utilized machine learning to select the ideal pH range needed for separating the carriers.

What sets this approach apart is its effectiveness of the pH gradient in segregating the exRNA carriers floating in the stream. When they pass through the pH gradient, the different types of carriers form lines along their isoelectric points, making it easy to channel them into separate outlets. The researchers could obtain incredibly pure samples—up to 97%—using less than a milliliter of body fluids like blood plasma, saliva, or urine. Moreover, while the best current technologies take around a day to separate samples, this new device accomplished the task in just 30 minutes.

“Noncommunicable diseases are responsible for more than 70 percent of deaths worldwide, and cardiovascular disease and cancer are responsible for most of that number,” said postdoctoral fellow Himani Sharma who served as project lead. “Our technology shows a path to improving the way clinicians diagnose these diseases, and that could save a tremendous number of lives.”

Related Links:
University of Notre Dame


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Urine Analyzer
respons® UDS100
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.